Read Larry Connors' blog – Short Term Trading Strategies
John Ricardi has over 25 years of business development and operational management experience in life sciences and semiconductor industries. He joined MIT in 2007 as vice president of business development, and was shortly thereafter promoted to Chief Operating Officer. John's underlying mission since joining MIT has been to create the necessary sales and marking strategy for the MIT 1000 Rapid Microbial Identification (ID) System. He has been working closely with the technical team here at MIT to productize the system and meet the appropriate market requirements.
In his roles thus far, John has been able to complete a major part of the primary execution plan for the Company's microbe identification technology, including MIT 1000 product validation by local contract laboratories, USDA Advanced Research Service, and -- most recently -- achieving AOAC Research Institute's Performance Test Method (PTM) certification for Listeria. In addition, John was integral in securing the strategic partner in Asia, OPH, to expand our business in that region. This achievement has also garnered access for the Company to potential leaders in the food processing market in Asia to support system-based sales of the MIT 1000.
"With John's technical background, his business development experience and thorough knowledge of our intended markets, we were very pleased to add him to our team two years ago. His leadership and management skills, in combination with MIT's technical talent, has enabled MIT to achieve several key milestones in its commercialization plan," stated Michael Brennan, MIT's Chairman and CEO. "We have now moved into the next phase of our commercialization plan, and have outlined a plan to aggressively grow the business that includes organic development coupled with new strategic distribution partners and potential acquisitions."
About Micro Imaging Technology:
MIT is a California-based public company that has developed and patented a rapid microbial ID System that can revolutionize the pathogenic ID process, by saving tens of millions of dollars and thousands of lives annually. The Company's system identifies bacteria contamination on food products in minutes, not days, and at a significant per test cost savings when compared to all existing conventional method. MIT's ID Systems does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis, thus is totally GREEN requiring only clean water and a sample of the unknown bacteria. Industry revenues for rapid testing methods in the U.S. alone currently exceed $5 billion annually, with food safety accounting for over $3 billion. This industry has expanded at a rate of 9.2 percent annually since 1998. Current growth projections are at 30 percent annually, with test demands being driven by major health, safety and homeland security issues.
The MIT 1000 System has numerous ID applications including food quality control, clinical diagnostics, pharmaceutical quality assurance, semiconductor processing control and water quality monitoring. The System is laser-based and uses the proven principles of light scattering in conjunction with proprietary PC-based software algorithms to ID microbes and create a proprietary database. MIT, through independent testing, has proven the ability with high accuracy to ID the most dangerous and pervasive pathogens; E. coli, Listeria, Salmonella, and Staphylococcus aureus (a.k.a. Staph) and twenty (20) other species of bacterium. MIT has chosen to focus initial efforts on food quality control, as recent events have created an urgent demand for quicker and cheaper testing; these demands will promote a high-value return on any investment in MIT's technology.
Please visit MIT's corporate Web site: www.micro-imaging.com
This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.
CONTACT: Michael Brennan Chairman Email: Email Contact Telephone: (805) 557-0614
SOURCE: Micro Imaging Technology, Inc.
http://www2.marketwire.com/mw/emailprcntct?id=5C410ACD7E5C3F12
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
